These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 37560164)

  • 1. Noncoding RNAs: an emerging modulator of drug resistance in pancreatic cancer.
    Wei L; Sun J; Wang X; Huang Y; Huang L; Han L; Zheng Y; Xu Y; Zhang N; Yang M
    Front Cell Dev Biol; 2023; 11():1226639. PubMed ID: 37560164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer.
    Wei L; Sun J; Zhang N; Shen Y; Wang T; Li Z; Yang M
    Front Cell Dev Biol; 2021; 9():764313. PubMed ID: 34881242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncoding RNAs in drug-resistant pancreatic cancer: A review.
    Lin Z; Lu S; Xie X; Yi X; Huang H
    Biomed Pharmacother; 2020 Nov; 131():110768. PubMed ID: 33152930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncoding RNAs in gastric cancer: implications for drug resistance.
    Wei L; Sun J; Zhang N; Zheng Y; Wang X; Lv L; Liu J; Xu Y; Shen Y; Yang M
    Mol Cancer; 2020 Mar; 19(1):62. PubMed ID: 32192494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
    Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
    Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer.
    Wang Y; Wang Y; Qin Z; Cai S; Yu L; Hu H; Zeng S
    Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):291-306. PubMed ID: 33544643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in the contribution of noncoding RNAs to cisplatin resistance in cervical cancer.
    Wen X; Liu S; Sheng J; Cui M
    PeerJ; 2020; 8():e9234. PubMed ID: 32523813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA GSTM3TV2 upregulates LAT2 and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic cancer.
    Xiong G; Liu C; Yang G; Feng M; Xu J; Zhao F; You L; Zhou L; Zheng L; Hu Y; Wang X; Zhang T; Zhao Y
    J Hematol Oncol; 2019 Sep; 12(1):97. PubMed ID: 31514732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting non-coding RNAs to overcome cancer therapy resistance.
    Chen B; Dragomir MP; Yang C; Li Q; Horst D; Calin GA
    Signal Transduct Target Ther; 2022 Apr; 7(1):121. PubMed ID: 35418578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical value of circular RNAs and autophagy-related miRNAs in the diagnosis and treatment of pancreatic cancer.
    Jiang PC; Bu SR
    Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):511-516. PubMed ID: 31610988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Non-Coding RNAs in the Sorafenib Resistance of Hepatocellular Carcinoma.
    Hu X; Zhu H; Shen Y; Zhang X; He X; Xu X
    Front Oncol; 2021; 11():696705. PubMed ID: 34367979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncoding RNAs in osteosarcoma: Implications for drug resistance.
    Lin Z; Xie X; Lu S; Liu T
    Cancer Lett; 2021 Apr; 504():91-103. PubMed ID: 33587978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noncoding RNAs in esophageal cancer: A glimpse into implications for therapy resistance.
    Yang Z; Ma R; Li J; Zhao L
    Pharmacol Res; 2023 Feb; 188():106678. PubMed ID: 36709789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncoding RNAs as novel immunotherapeutic tools against cancer.
    Kaur M; Kaur B; Konar M; Sharma S
    Adv Protein Chem Struct Biol; 2022; 129():135-161. PubMed ID: 35305717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Coding RNAs in Pancreatic Cancer Diagnostics and Therapy: Focus on lncRNAs, circRNAs, and piRNAs.
    Li Y; Al Hallak MN; Philip PA; Azmi AS; Mohammad RM
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-angiogenic Drug Resistance: Roles and Targeting of Non-coding RNAs (microRNAs and long non-coding RNAs).
    Dashtaki ME; Ghasemi S
    Curr Mol Pharmacol; 2023; 16(8):855-869. PubMed ID: 36475334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging role of noncoding RNAs in colorectal cancer chemoresistance.
    Wei L; Wang X; Lv L; Zheng Y; Zhang N; Yang M
    Cell Oncol (Dordr); 2019 Dec; 42(6):757-768. PubMed ID: 31359293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer.
    Xie W; Chu M; Song G; Zuo Z; Han Z; Chen C; Li Y; Wang ZW
    Semin Cancer Biol; 2022 Aug; 83():303-318. PubMed ID: 33207266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncoding RNAs: New Players in Cancers.
    Chen X; Fan S; Song E
    Adv Exp Med Biol; 2016; 927():1-47. PubMed ID: 27376730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy.
    Di Martino MT; Riillo C; Scionti F; Grillone K; Polerà N; Caracciolo D; Arbitrio M; Tagliaferri P; Tassone P
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33808190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.